These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 3826060)

  • 1. Differences between membranoproliferative glomerulonephritis types I and III in clinical presentation, glomerular morphology, and complement perturbation.
    Jackson EC; McAdams AJ; Strife CF; Forristal J; Welch TR; West CD
    Am J Kidney Dis; 1987 Feb; 9(2):115-20. PubMed ID: 3826060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M; Sich M; Habib R
    Arch Fr Pediatr; 1979 Nov; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Partial lipodystrophy, hypocomplementemia and glomerulonephritis].
    Habib R; Lévy M; Gubler MC; Broyer M; Habib M
    Arch Fr Pediatr; 1977; 34(7 Suppl):CXCVII-CCXII. PubMed ID: 931525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of complement activation in idiopathic membranoproliferative glomerulonephritis, types I, II, and III.
    Varade WS; Forristal J; West CD
    Am J Kidney Dis; 1990 Sep; 16(3):196-206. PubMed ID: 2205097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
    West CD; McAdams AJ
    Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membranoproliferative glomerulonephritis. Localization of early components of complement in glomerular deposits.
    Davis BK; Cavallo T
    Am J Pathol; 1976 Aug; 84(2):283-98. PubMed ID: 133617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
    Meyers KE; Strife CF; Witzleben C; Kaplan BS
    Am J Kidney Dis; 1996 Dec; 28(6):804-10. PubMed ID: 8957031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
    J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
    Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
    Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC; West CD; Strife CF
    Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic rapidly progressive glomerulonephritis with C3 nephritic factor and hypocomplementemia.
    Davis CA; McAdams AJ; Wyatt RJ; Forristal J; McEnery PT; West CD
    J Pediatr; 1979 Apr; 94(4):559-63. PubMed ID: 372512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical complement pathway activation in membranoproliferative glomerulonephritis.
    Ooi YM; Vallota EH; West CD
    Kidney Int; 1976 Jan; 9(1):46-53. PubMed ID: 781380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A properdin dependent nephritic factor slowly activating C3, C5, and C9 in membranoproliferative glomerulonephritis, types I and III.
    Clardy CW; Forristal J; Strife CF; West CD
    Clin Immunol Immunopathol; 1989 Mar; 50(3):333-47. PubMed ID: 2917424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
    Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP; Pertosa G; Stanziale P; Vox E; Pecoraro C; Andreucci VE
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephritic factor: Description of a new quantitative assay and findings in glomerulonephritis.
    Border WA; Wilson CB; Götze O
    Kidney Int; 1976 Oct; 10(4):311-8. PubMed ID: 62864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct detection C3bBb stabilizing activity in sera from hypocomplementaemic membranoproliferative glomerulonephritis (MPGN) and complement profiles of C3NeF positive cases].
    Watanabe S; Ohi H; Seki M; Fujita T; Hatano M
    Nihon Jinzo Gakkai Shi; 1985 Oct; 27(10):1345-52. PubMed ID: 4094159
    [No Abstract]   [Full Text] [Related]  

  • 20. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane.
    Strife CF; McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1977 Feb; 7(2):65-72. PubMed ID: 844227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.